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ABSTRACT 
In pyrazine mesomeric interaction between the protonated & neutral nitrogen atoms probably destabilizes the cation.N, N’-diprotonation is 
very easier for pyrazine Synthesis of 2, 3-diphenylquinoxaline by phenylene-diamine in 16 ml of rectified spirit was added & combine solution 
was warm in water bath for 30 min. added water until slight colorless persist & allow to cool recrystallize the product in ethanol.   Synthesis of 
2, 3-diphenylquinoxaline 7-sulfonylchloride (R) using chlorosulfonic acid under ice-cold condition, then Synthesis of  2-hydroxyphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R1) throughresorcinol with 3ml pyridine & sulphonyl chloride derivative, Synthesis of 2-formylphenyl-2,3-
diphenylquinoxaline-7-sulphonate(R7)obtained by reaction of salicylaldehyde with pyridine & sulphonyl chloride derivative then Synthesis of 
3-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate(R9) obtained by heating on water bath mixture of3-hydroxybenzaldehyde with pyridine 
& sulphonyl chloride, Synthesized quinoxaline derivatives were subjected to antimicrobial susceptibility testing by well diffusion method 
against gram positive (S.aureus, 2079) and gram negative bacteria (E. coli, 2685). The results of quinoxaline derivatives in terms of zone of 
inhibition recorded. MIC of quinoxaline derivative was determined by tube micro dilution technique against S. aureus and E. coli. The turbidity 
was measured by UV at about 420 nm. Hydrogen peroxide scavenging activity and 1, 1 diphenyl 2, picryl hydrazyl Method (DPPH) calculated 
and Most of the derivatives have shown comparable antioxidant activity in relation to standard Ascorbic acid and DPPH.   
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INTRODUCTION: 
Heterocyclic chemistry To provide an understanding of 
principles of the medicinal chemistry, it is necessary to 
consider the physicochemical properties used to develop 
new pharmacologically active compounds and their 
mechanism of action, the drug’s metabolism including 
possible biological activities of the metabolites, the 
importance of stereochemistry in drug design, and the 
methods used to determine what ‘space’ a drug occupies. All 
of the principles are based on the fundamental organic 
chemistry, physical chemistry and biochemistry. The 
diazines are essentially monobasic substances and 
considerably weaker as bases than pyridine. In pyrazine 
mesomeric interaction between the protonated & neutral 
nitrogen atoms probably destabilizes the cation.N, N’-
diprotonation is very easier for pyrazine.4 Chlorination of 2-
methyl pyrazine occurs under such mild condition that it is 
almost certain that an addition / elimination sequence is 
involved, rather than a classical aromatic electrophilic 
substitution The diazines are generally resistant to oxidative 
attack at ring carbons through alkaline oxidizing agent can 
bring about degradation via intermediate produced by initial 
nucleophilic addition. Alkyl substituents fused aromatic rings 
can be oxidized to carboxylic acid residue leaving the 
heterocyclic ring untouched. Pyrazine N-oxide can be readily 
prepared by oxidation of parent heterocycle. Pyrazine N-
oxide behaves like their pyridine counterparts in 
electrophilic substitution & nucleophilic displacement 
reaction involving loss of the oxygen. 
The broth and agar dilution methods are to determine the 
lowest concentration of the assayed antimicrobial that 
inhibits the growth of the bacterium being tested (MIC, 
usually expressed in mg/ml or mg/liter). However, the MIC 
does not always represent an absolute value. The ‘true’ MIC 
is a point between the lowest test concentration that inhibits 
the growth of the bacterium and the next lower test 
concentration. Therefore, MIC determinations performed 
using a dilution series may be considered to have an inherent 
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variation of one dilution. Antimicrobial ranges should 
encompass both the interpretive criteria (susceptible, 
intermediate and resistant) for a specific 
bacterium/antibiotic combination and appropriate quality 
control reference organisms. Antimicrobial susceptibility 
dilution methods appear to be more reproducible and 
quantitative than agar disk diffusion. However, antibiotics 
are usually tested in doubling dilutions, which can produce 
inexact MIC data. Thus, Asuncion Burguete et al., synthesized 
novel ring substituted 3-phenyl -1- (1, 4-di-N-oxide 
quinoxaline-2-yl) -2-propen-1-one derivatives and of their 4, 
5-dihydro-(1H)-pyrazole analogues. Synthesized compounds 
were evaluated for anti-inflammatory and antioxidant 
activity. The tested compounds inhibit the carrageenan-
induced rat paw edema (4.5-56.1%) and present important 
scavenging activities.i .M.Ali et.al, synthesized some novel 
quinoxalinone derivative and evaluated for antimicrobial 
activity. Condensation of 4-benzoyl-1, 2-phenylenediamine 
with sodium pyruvate in acetic acid furnished two product 
which were identified as 6-benzoyl and 7-benzoyl-3-methyl-
2(1H) quinoxalinone.ii Alireza Hasaninejad, Abdolkarim Zare, 
et.al, reported Bentonite Clay K-10 as an Efficient Reagent for 
the Synthesis of Quinoxaline Derivatives at Room 
Temperature. Bentonite clay K-10 acts as an efficient reagent 
for the preparation of quinoxaline derivatives via the 
condensation of aryl and alkyl 1,2-diamines with α-diketones 
in ethyl alcohol as a green media at room temperature.iii 
MATERIALS AND METHODS: 
Derivatives of 2,3-diphenylquinoxaline-7-sulphonyl chloride 
with Aldehydes.
 
 
Experimental Methods: 
Synthesis of 2, 3-diphenylquinoxaline 
NH2
NH2
+ O
O
Ethanol
Heat for 30 min.
N
N
benzene-1,2-diamine
2,3-diphenylquinoxaline
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To warm solution of 4.2 gram of benzyl in 16 ml of rectified 
spirit, the solution of 2.2ml of o-phelyne diamine in 16 ml of 
rectified spirit was added & combine solution was warm in 
water wath for 30 min. added water until slight colourless 
persist & allow to cool. Filter & recrystallize the product in 
ethanol.    
Synthesis of 2, 3-diphenylquinoxaline 7-sulfonylchloride 
(R) 
0.01 moles of 2, 3 diphenylquinoxaline (2.82g) was treated 
with Chlorosulfonic acid under ice-cold condition in fuming 
cupboard with constant stirring. The stirring was continued 
until the reaction reaches room temperature. The resultant 
mixture was poured into water to give sulfonylchloride 
derivative.1 
Synthesis of phenol derivatives of 2, 3-
diphenylquinoxaline-7-sulphonyl chloride: 
Synthesis of  2-hydroxyphenyl-2,3-diphenylquinoxaline-7-
sulphonate(R1) 
Mix 1.17gm of  resorcinol with 3ml pyridine & 2.34 gm of 
sulphonyl chloride derivative &heat on water bath for 1 hr. 
pour into 25 ml of cold water & stir until the oil solidifies , 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present &them with cold water, 
recrystallized from methanol or ethanol.
 
Synthesis of 2-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate(R7)  
N
NClO2S Salicylaldehyde, Pyridine
Heat for 1.5 hr.
N
NSO
CH
O
O
O
2,3-diphenylquinoxaline-
-7-sulphonyl chloride
2-formylphenyl-2,3-diphenyl-
quinoxaline-7-sulphonate
 
 
Mix 1.29 gm of  salicylaldehyde with 3.22ml pyridine & 2.58 
gm of sulphonyl chloride derivative &heat on water bath for 
1.5 hr. pour into 25 ml of cold water & stir until the oil 
solidifies , filter wash with cold dil HCl to remove pyridine 
and cold dil NaOH  to remove any phenol present &them 
with cold water , recrystallized from methanol or ethanol.
 
Synthesis of 4-formyl-3-methoxyphenyl-2,3-diphenylquinoxaline-7-sulphonate (R8) 
N
NClO2S Vanillin, Pyridine
Heat for 3 hr.
N
NSOCH
H3CO
O O
O
 
Mix 1.61 gm of  vanillin with4.02 ml pyridine & 3.22 gm of 
sulphonyl chloride derivative & heat on water bath for 3 hr. 
pour into 25 ml of cold water & stir until the oil solidifies, 
filter wash with cold dil HCl to remove pyridine and cold dil 
NaOH  to remove any phenol present &them with cold water, 
recrystallized from methanol or ethanol.
 
Synthesis of 3-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate(R9) 
N
NClO2S 3-hydroxybenzaldehyde, Pyridine
Heat for 2.15 hr.
N
NSO
CH
O
O
O
 
Mix 1.29 gm of  3-hydroxybenzaldehyde with 3.22ml 
pyridine & 2.58 gm of sulphonyl chloride derivative &heat 
on water bath for 2.15 hr. pour into 25 ml of cold water & 
stir until the oil solidifies , filter wash with cold dil HCl to 
remove pyridine and cold dil NaOH  to remove any phenol 
present &them with cold water , recrystallized from 
methanol or ethanol.
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Synthesis of S-2-formylphenyl-2,3-diphenylquinoxaline-7-sulphonate(R10) 
N
NClO2S 2-mercaptobenzaldehyde, Pyridine
Heat for 2 hr.
N
NSS
CH
O
O
O
 
 
Mix 1.46 gm of 2-mercapto benzaldehyde with 3.67ml 
pyridine & 2.92 gm of sulphonyl chloride derivative &heat on 
water bath for 2 hr. pour into 25 ml of cold water & stir until 
the oil solidifies, filter wash with cold dil HCl to remove 
pyridine and cold dil NaOH to remove any phenol present 
&them with cold water , recrystallized from methanol or 
ethanol. 
Identification &Characterization 
The identification & characterization of prepared compound 
were carried out on the basis of physical, chemical, and 
spectral data such as Melting point (MP), thin layer 
chromatography (TLC), Infrared Spectroscopy (IR), Mass 
Spectrometry (MS), Nuclear Magnetic Resonance 
Spectroscopy (1HNMR). 
Physical Properties  
Synthesized quinoxaline sulfonamide derivatives were 
evaluated for physical properties such as physical state, 
color, and melting point. 
Melting point 
Melting points of all derivatives were determined by Open 
capillary tube method. 
Solubility 
Solubility study of synthesized derivatives was carried out in 
different solvents like water, ethanol, methanol, acetone, 
benzene, chloroform, and DMF. 
Thin layer chromatography (TLC) 
All the synthesized derivatives were subjected to TLC 
analysis to ensure the completion of the reaction  
Determination of Minimum Inhibitory Concentration: 
Tube Dilution Technique 
Double strength nutrient broth was prepared by dissolving 
6.25 g of nutrient broth in 250 ml distilled water. The 
medium was boiled to aid dissolution and sterilized by 
autoclaving at 15 psi pressure (121˚C) for 20 min. 
1ml of double strength nutrient broth was added to a set of 
presterilized 5 test tubes (numbered from 1-5). To the first 
test tube, 1ml quinoxaline derivative sample solution 
(conc.=1000 µg/ml) was added. After thorough mixing, 1ml 
of solution from test tube no.1 was transferred to test tube 
no.2 so as to obtain concentration of 500µg/ml. The same 
procedure (serial dilution) was followed for the remaining 
test tubes from no. 3 to no. 5 to get the concentration in the 
range of 250µg/ml to 62.5µg/ml from 3rd to 5th test tube. 
From 5th test tube 1 ml of solution was discarded so as to get 
the equal volume in each test tube. Thus, each tube having 
concentration of 1000, 500, 250, 125, 62.5µg/ml. To each 
test tube 20 µl of Enterobacteria suspension was added 
(inoculation). All test tubes were incubated at 37˚C for 24 
hours and observed for turbidity. The sets of test tube were 
compared for determining the MIC. The whole experimental 
setup was repeated for S. aureus and E. coli. 
Table 1: Preparation of Medium 
Micro-organism S. aureus 
Media 
Double strength 
nutrient broth 
Conc. of quinoxaline derivative 1000µg/ml 
Loaded volume of media 1 ml 
Loaded volume of microbial suspension 20 µl 
Incubation temperature 37°C 
Incubation period 24 Hrs 
 
QSAR: 
Molecular Descriptors: 
Molecular descriptors can be defined as a numerical 
representation of chemical information encoded within a 
molecular structure via mathematical procedure. Type of 
QSAR is based on the dimensionality of molecular 
descriptors used: 
 0D these are descriptors derived from molecular 
formula e.g. molecular weight, number and type of 
atoms etc. 
 1D A substructure list representation of a molecule can 
be considered as a one dimensional (1D) molecular 
representation and consists of a list of molecular 
fragments (e.g. functional groups, rings, bonds, 
substituents etc.). 
 2D A molecular graph contains topological or two 
dimensional (2D) information describes how the atoms 
are bonded in a molecule, both the type of bonding and 
the interaction of particular atoms (e.g. total path 
count, molecular connectivity indices etc.). 
 3D These are calculated starting from a geometrical or 
3D representation of a molecule. These descriptors 
include molecular surface, molecular volume and other 
geometrical properties. There are different types of 3D 
descriptors e.g. electronic, steric, shape etc. 
 4D In addition to the 3D descriptors the 4th dimension 
is generally in terms of different conformations or any 
other experimental condition. 
RESULT AND DISCUSSION: 
Number of Rotatable Bonds – nrotb: 
This simple topological parameter is a measure of molecular 
flexibility. It has been shown to be a very good descriptor of 
oral bioavailability of drugs. Rotatable bond is defined as any 
single non-ring bond, bounded to non terminal heavy (i.e., 
non-hydrogen) atom. Amide C-N bonds are not considered 
because of their high rotational energy barrier. 
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Table 2: Predicted Values for GPCR ligands and kinase inhibitors of compounds 
Compound Nrotb Vol GPCR ligand Ion channel 
modulator 
Kinase 
inhibitor 
Nuclear receptor 
ligand 
R1 5 382.382 -0.17 -0.24 -0.35 -0.09 
R7 5 392.381 -0.14 -0.49 -0.12 -0.21 
R8 6 417.927 -0.45 -0.68 -0.18 -0.28 
R9 5 392.381 -0.17 -0.53 -0.17 -0.22 
R10 5 402.024 -0.43 -0.78 -0.41 -0.55 
 
Table 3: Physicochemical properties of synthesized quinoxaline derivatives 
Code no. M. P. (0C) Mol. wt Rf value Percent yield Mol. formula 
R1 92 460 0.39 80 C26H18N2O4S 
R7 86 472 0.2 83 C27H18N2O4S 
R8 62 502 0.44 75 C28H20N2O5S 
R9 90 472 0.35 82 C27H18N2O4S 
R10 94 488 0.8 84 C27H18N2O3S2 
 
Infra-red spectroscopy: 
All the synthesized derivatives were characterized by infra red spectroscopy in the range of 400-4000 cm-1 by KBr pellet 
technique. The IR spectra of all synthesized derivatives were as follows. 
N
NSO
CH
O
O
O
 
2-formylphenyl-2,3-diphenyl- quinoxaline-7-
sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1132.8(1180-1130) 
 1330.1( 1370-1300) 
 C=O 1695(1760-1690) 
Mono sub. Aromatic ring 762.3(770-735) 
CH aromatic 3046.6  ( 3100-3000) 
 
N
NSOCH
H3CO
O O
O
            4-
formyl-3-methoxyphenyl-2,3--diphenyl- quinoxaline-7-
sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1132.8(1180-1130) 
 1334.9( 1370-1300) 
 C=O 1691(1760-1690) 
Mono sub. Aromatic ring 762.4(770-735) 
CH aromatic 3046.6  ( 3100-3000) 
 
N
NSO
CH
O
O
O
3-
Formylphenyl-2,3-diphenylquinoxaline-7-
sulphonate 
Fuctional group Frequency(cm-1) 
S=O 1136(1180-1130) 
 1342.4( 1370-1300) 
 C=O 1691(1760-1690) 
Mono sub. Aromatic ring 767.6(770-735) 
CH aromatic 3055 ( 3100-3000) 
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Pharmacological Screenings: 
Antimicrobial Susceptibility Testing: 
Synthesized quinoxaline derivatives were subjected to 
antimicrobial susceptibility testing by well diffusion method 
against gram positive (S.aureus, 2079) and gram negative 
bacteria (E. coli, 2685). The results of quinoxaline derivatives 
in terms of zone of inhibition were as follows; 
            
Table 4: Zone of inhibition against S. aureus 
Quinoxaline derivative Zone of inhibition (mm.) 
2OOµg.  S.aureus 
Zone of inhibition (mm.) 
400 µg. S.aureus 
Azithromycin (s) 18 37 
R1 - - 
R7 - - 
R8 - - 
R9 11 21 
R10 - - 
 
Table 5: Zone of inhibition againstE. coli 
Quinoxaline 
derivative 
Zone of inhibition (mm.) 2OOµg. 
E.coli 
Zone of inhibition (mm.) 
400 µg. E.coli 
Azithromycin (s) 17 33 
R1 - - 
R7 - - 
R8 - - 
R9 09 18 
R10 - - 
Azithromycin is used as Reference drug and a comparative study was done. As compare to reference drug all derivatives shows 
less sensitivity but R9 shows better sensitivity than other derivatives. 
 
Determination of MIC: 
MIC of quinoxaline derivative was determined by tube micro dilution technique against S.aureus and E. coli. The turbidity was 
measured by UV at about 420 nm. The results of MIC were found to be as follows. 
Table 6: Results for MIC of quinoxaline derivatives against S. aureus 
Quinoxaline Derivative Absorbance at 420 nm. 
Conc. (µg/ml) 200 400 800 1000 
S 0.865 0.851 0.621 0.271 
R9 0.432 0.351 0.274 0.243 
 
As per the data obtained after micro broth dilution method, the antimicrobial activity of drug derivative R4 found to be effective 
in between the range of 800-1000µg/ml where as that of R9 was above 1000µg against S. aureus. 
Table 7: Results for MIC of quinoxaline derivatives against E. coli 
Quinoxaline Derivative Absorbance at 420 nm. 
Conc. (µg/ml) 200 400 800 1000 
S 0.705 0.580 0.436 0.365 
R9 0.295 0.258 0.230 0.215 
 
As per the data obtained after micro broth dilution method, the antimicrobial activity of drug derivative R4 found to be effective 
in between the range of 400-800µg/ml where as that of R9 was above 1000µg against E. coli. 
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CONCLUSION: 
The objective of the present study was to synthesize some 
new 7-sulfonate of 2, 3- Diphenyl quinoxaline which are 
more potential as antibacterial than parent 
quinoxalines.1QSAR study gives idea about various 
descriptors of different derivatives and Docking gives idea 
about having more affinity towards gamma Glutamyl-
transpeptidase enzyme. In future similar methods can be 
used for 3-Methyl 2-(1H) quinoxalinone. Synthesis of 
derivatives of sulfonyl chloride quinoxaline and 
physicochemical and spectral characterization, in vitro 
antimicrobial screening against gram positive and gram 
negative bacteria. The reaction was carried out in the 
presence of base, (NaOH) was used, and all the reaction was 
refluxed on water bath. The reaction time required for each 
reaction was different it was depends on the aldehydes used. 
All the derivatives were confirmed by TLC, IR, and 1HNMR. 
The spectral characterization revealed the formation of 
sulfonates. The newly synthesized aldehydes derivatives 
were screened for antimicrobial activity. All the derivatives 
were then subjected to antimicrobial susceptibility testing 
against gram positive (S. aureus) and gram negative bacteria 
(E. coli). Also, antimicrobial data of quinoxaline derivatives 
was obtained. It was found that sulfonyl chloride 
quinoxaline derivatives have pronounced effect as compared 
to antibiotic Azithromycin, present in the market against 
both the gram positive and gram negative bacteria.  
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